Human immunodeficiency virus (HIV) affects millions of childrenworldwide. Newpediatric cases are continuing to be diagnosed. However, with the approval and use of various newprotocols andantiretroviral agents, transmission rates in perinatally exposed infants have dramatically declined and survival of HIV-infected children has been prolonged. Pre-vention education is the starting point to try to reduce future transmission; however, increases in HIV cases continue to be seen in the adolescent population. Current pharmacological therapy of HIV includes amultidrug regimen with the poten-tial for numerousdrug-drug interactions, adverse effects, and development of resistance. Routine monitoring of adherence is required to try to attain and susta...
Introduction: The new “90-90-90” UNAIDS agenda proposes that 90% of all people living with HIV will ...
BACKGROUND: Treating HIV-infected children remains a challenge due to a lack of treatment options, a...
working group to develop guidelines for therapy of human immunodeficiency virus (HIV)-associated opp...
Pediatric HIV/AIDS has become less of a problem in resource-rich countries as the number of perinata...
Perinatal transmission remains the main cause of HIV infection in the pediatric population. Treatmen...
INTRODUCTION: Current international guidelines recommend to treat all HIV-1 infected patients regard...
Contains fulltext : 59063.pdf (publisher's version ) (Open Access)Current treatmen...
Susan J Schuval1,21Division of Allergy/immunology, Department of Pediatrics, North Shore –...
Effective prevention strategies have reduced the risk of perinatal transmission of human immunodefic...
Background: Treating HIV-infected children remains a challenge due to a lack of treatment options, a...
Human immunodeficiency virus (HIV) infection in infants and young children differs in a number of wa...
Paediatric HIV infection is a substantial global public health problem in its own right. Approximate...
Introduction of Highly Active Antiretroviral Therapy (HAART) and implementation of preventive strate...
BACKGROUND: A number of well-described obstacles to the pediatric therapeutic agenda have resulted i...
Selection of the most effective and safest high-active antiretroviral therapies is a critical issue ...
Introduction: The new “90-90-90” UNAIDS agenda proposes that 90% of all people living with HIV will ...
BACKGROUND: Treating HIV-infected children remains a challenge due to a lack of treatment options, a...
working group to develop guidelines for therapy of human immunodeficiency virus (HIV)-associated opp...
Pediatric HIV/AIDS has become less of a problem in resource-rich countries as the number of perinata...
Perinatal transmission remains the main cause of HIV infection in the pediatric population. Treatmen...
INTRODUCTION: Current international guidelines recommend to treat all HIV-1 infected patients regard...
Contains fulltext : 59063.pdf (publisher's version ) (Open Access)Current treatmen...
Susan J Schuval1,21Division of Allergy/immunology, Department of Pediatrics, North Shore –...
Effective prevention strategies have reduced the risk of perinatal transmission of human immunodefic...
Background: Treating HIV-infected children remains a challenge due to a lack of treatment options, a...
Human immunodeficiency virus (HIV) infection in infants and young children differs in a number of wa...
Paediatric HIV infection is a substantial global public health problem in its own right. Approximate...
Introduction of Highly Active Antiretroviral Therapy (HAART) and implementation of preventive strate...
BACKGROUND: A number of well-described obstacles to the pediatric therapeutic agenda have resulted i...
Selection of the most effective and safest high-active antiretroviral therapies is a critical issue ...
Introduction: The new “90-90-90” UNAIDS agenda proposes that 90% of all people living with HIV will ...
BACKGROUND: Treating HIV-infected children remains a challenge due to a lack of treatment options, a...
working group to develop guidelines for therapy of human immunodeficiency virus (HIV)-associated opp...